Selected high-value unpartnered assets according to BioPharma Dealmakers
To coincide with the start of the annual JP Morgan conference #JPM18 — typically an event where major #pharma#deals are announced — we highlight some of the most valuable #assets that are currently unpartnered, using data provided by @evaluatepharmapic.twitter.com/FdTTzqkuHm
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.